Hong Bu

966 total citations · 1 hit paper
39 papers, 729 citations indexed

About

Hong Bu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hong Bu has authored 39 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Hong Bu's work include Sarcoma Diagnosis and Treatment (7 papers), Soft tissue tumor case studies (4 papers) and TGF-β signaling in diseases (4 papers). Hong Bu is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Soft tissue tumor case studies (4 papers) and TGF-β signaling in diseases (4 papers). Hong Bu collaborates with scholars based in China and United States. Hong Bu's co-authors include Jie Chen, Yu-Yao Zhu, Jinpei Zhou, Wen‐Ming Cong, Xinrui Yuan, Hui Dong, Long-Hai Feng, Jun Chen, Chao‐Yie Yang and Huibin Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Hong Bu

38 papers receiving 715 citations

Hit Papers

Practice guidelines for the pathological diagnosis of pri... 2016 2026 2019 2022 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update
    2016 274 citations Wen‐Ming Cong, Hong Bu et al. World Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Bu China 11 253 221 157 142 128 39 729
Tsui‐Lien Mao Taiwan 14 500 2.0× 121 0.5× 321 2.0× 161 1.1× 120 0.9× 24 1.0k
D. Ockert Germany 15 358 1.4× 142 0.6× 582 3.7× 193 1.4× 212 1.7× 47 1.2k
Katsura Emoto Japan 19 272 1.1× 40 0.2× 338 2.2× 316 2.2× 114 0.9× 63 898
Paola Bossi Italy 11 352 1.4× 160 0.7× 462 2.9× 159 1.1× 244 1.9× 30 1.0k
M. Paganuzzi Italy 16 257 1.0× 65 0.3× 331 2.1× 518 3.6× 115 0.9× 38 992
Rossana Maffei Italy 22 357 1.4× 104 0.5× 230 1.5× 64 0.5× 57 0.4× 46 1.2k
Wenqing Wang China 15 205 0.8× 57 0.3× 213 1.4× 252 1.8× 180 1.4× 76 632
Yu Mei United States 18 193 0.8× 245 1.1× 78 0.5× 52 0.4× 146 1.1× 26 921
Ashton A. Connor United States 14 250 1.0× 58 0.3× 520 3.3× 94 0.7× 272 2.1× 50 859
Feifei Na China 14 210 0.8× 48 0.2× 166 1.1× 224 1.6× 78 0.6× 33 618

Countries citing papers authored by Hong Bu

Since Specialization
Citations

This map shows the geographic impact of Hong Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Bu more than expected).

Fields of papers citing papers by Hong Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Bu. The network helps show where Hong Bu may publish in the future.

Co-authorship network of co-authors of Hong Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Bu. A scholar is included among the top collaborators of Hong Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Bu. Hong Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Xinrui, Chao Chen, Hong Bu, et al.. (2024). Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of Lymphoma. Journal of Medicinal Chemistry. 67(7). 5437–5457. 5 indexed citations
2.
Zhong, Xiaorong, Ping He, Jie Chen, et al.. (2022). Neoadjuvant pyrotinib plus trastuzumab and nab-paclitaxel for HER2-positive early or locally advanced breast cancer: an exploratory phase II trial. Gland Surgery. 11(1). 216–225. 14 indexed citations
3.
Bu, Hong, et al.. (2021). Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors. Bioorganic & Medicinal Chemistry. 40. 116186–116186. 7 indexed citations
4.
Gao, Hongwei, Lin Xiao, Qiuxiao Yu, et al.. (2020). Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance. Journal of Biological Chemistry. 295(31). 10726–10740. 10 indexed citations
5.
Yuan, Xinrui, Hong Bu, Jinpei Zhou, Chao‐Yie Yang, & Huibin Zhang. (2020). Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. Journal of Medicinal Chemistry. 63(20). 11368–11396. 160 indexed citations
6.
Yang, Libo, Ting Lei, Li Li, et al.. (2019). BRCA1/2 mutation spectrum in Chinese early-onset breast cancer. Translational Cancer Research. 8(2). 483–490. 1 indexed citations
7.
Yuan, Xinrui, et al.. (2019). Design, synthesis and biological evaluation of pyridone–aminal derivatives as MNK1/2 inhibitors. Bioorganic & Medicinal Chemistry. 27(7). 1211–1225. 11 indexed citations
8.
Yuan, Xinrui, et al.. (2018). Targeting the immunity protein kinases for immuno-oncology. European Journal of Medicinal Chemistry. 163. 413–427. 14 indexed citations
9.
Wang, Enhua, Minghua Zhu, Hong Bu, et al.. (2016). [Consensus of Chinese experts on detection of related drive genes in target therapy of non-small cell lung cancer].. PubMed. 45(2). 73–7. 2 indexed citations
10.
Cong, Wen‐Ming, Hong Bu, Jie Chen, et al.. (2016). Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World Journal of Gastroenterology. 22(42). 9279–9279. 274 indexed citations breakdown →
11.
Chen, Younan, Yang Ding, Lingling Wei, et al.. (2009). Reference values of clinical chemistry and hematology parameters in rhesus monkeys (Macaca mulatta). Xenotransplantation. 16(6). 496–501. 56 indexed citations
12.
Wang, Wei, Peng Zhang, Jinjing Wang, & Hong Bu. (2008). Cyclosporine A aggravates vascular endothelial injury in hyperlipidemic rats by down-regulating decay-accelerating factor. Biochemical and Biophysical Research Communications. 379(1). 27–31. 4 indexed citations
13.
Guo, Hua, et al.. (2007). Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma. Chinese Medical Journal. 120(6). 515–521. 11 indexed citations
14.
Zhang, Hongying, et al.. (2006). Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells. International Journal of Oncology. 29(5). 1149–57. 11 indexed citations
15.
Lu, Yue, et al.. (2005). The characteristics of tolerogenic plasmacytoid dendritic cells stimulated with interleukin-3. Transplantation Proceedings. 37(1). 7–9. 3 indexed citations
16.
Chen, Huijiao, Hongying Zhang, Xiang Li, et al.. (2004). [Solitary fibrous tumor: the clinicopathologic and immunohistochemical characteristics of 26 cases].. PubMed. 35(5). 675–9. 4 indexed citations
17.
Guo, Hua, et al.. (2004). [Diffuse malignant deciduoid peritoneal mesothelioma--a case report].. PubMed. 33(3). 297–8. 1 indexed citations
18.
Wang, Hua, et al.. (2003). Systematic analysis of the TGF‐β/Smad signalling pathway in the rhabdomyosarcoma cell line RD. International Journal of Experimental Pathology. 84(3). 153–163. 17 indexed citations
19.
Lu, Xiaofeng, Jie Zhang, Zhen Zhang, et al.. (2002). [Osteogenesis of HA/TCP biphasic ceramics implanted into muscle: a long-term study].. PubMed. 19(3). 361–4. 4 indexed citations
20.
Bu, Hong, et al.. (2000). Xenoantigenacity of Chinese Neijiang pig-related to xenotransplantation. Transplantation Proceedings. 32(5). 875–876. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsui‐Lien Mao Breakdown of academic impact, for papers by D. Ockert Breakdown of academic impact, for papers by Katsura Emoto Breakdown of academic impact, for papers by Paola Bossi Breakdown of academic impact, for papers by M. Paganuzzi Breakdown of academic impact, for papers by Rossana Maffei Breakdown of academic impact, for papers by Wenqing Wang Breakdown of academic impact, for papers by Yu Mei Breakdown of academic impact, for papers by Ashton A. Connor Breakdown of academic impact, for papers by Feifei Na
Rankless by CCL
2026